Neoplasm Metastasis  >>  hydrocortisone  >>  Phase 2
Welcome,         Profile    Billing    Logout  

3 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
hydrocortisone / Generic mfg.
NCT00623766: Evaluation of Tumor Response to Ipilimumab in the Treatment of Melanoma With Brain Metastases

Checkmark P2 data
Nov 2012 - Nov 2012: P2 data
Checkmark P2 data
Mar 2012 - Mar 2012: P2 data
Checkmark Data
More
Completed
2
99
US
Ipilimumab, BMS-734016, MDX-010, Corticosteroid: Betamethasone, Corticosteroid: Dexamethasone, Corticosteroid: Fludrocortisone, Corticosteroid: Hydrocortisone, Corticosteroid: Meprednisone, Corticosteroid: Methylprednisolone, Corticosteroid: Prednisolone, Corticosteroid: Prednisone, Corticosteroid: Triamcinolone
Bristol-Myers Squibb, Medarex
Melanoma
09/09
10/12
NCT01267266: Saracatinib in Treating Patients With Prostate Cancer

Terminated
2
31
US
saracatinib, AZD0530, hydrocortisone/placebo
National Cancer Institute (NCI)
Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer, Stage IV Prostate Cancer
09/12
11/13
LUTRAERL, NCT00473083: Systemic and Topical Treatments for Rash Secondary to Erlotinib in Lung Cancer

Completed
2
150
Canada
Minocycline, Dynacin, Minocin, Minocin PAC, Solodyn, Vectrin, Myrac, Clindamycin 2% in hydrocortisone 1% lotion, Erlotinib, Tarceva, Topical clindamycin 2%, triamcinolone acetonide 0.1% soln
British Columbia Cancer Agency, Hoffmann-La Roche
Rash
12/12
08/13

Download Options